<b>Viriom</b> Obtains First Market Approval Of Elsulfavirine (Elpida) For Treatment Of HIV-1 Infection In Russia Post author:Sam Post published:July 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Blueprint Medicines To Report Second Quarter 2017 Financial Results On Wednesday, August 2, 2017 July 25, 2017 OrbiMed To Raise $450 Million For Third Asia Life Science Fund March 2, 2017 FDA Hails Novartis' Kisqali a Breakthrough January 2, 2018
Blueprint Medicines To Report Second Quarter 2017 Financial Results On Wednesday, August 2, 2017 July 25, 2017